I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
96-week results of a dual therapy with darunavir/ritonavir ..:
Valentina Di Cristo
;
Fulvio Adorni
;
Renato Maserati
...
http://dx.doi.org/10.1080/25787489.2020.1734752. , 2020
Link:
https://doi.org/10.1080/25787489.2020.1734752
RT Journal T1
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:11cbccd78926440a8f62a94c85f8086a&Exemplar=1&LAN=DE A1 Valentina Di Cristo A1 Fulvio Adorni A1 Renato Maserati A1 Marco Annovazzi Lodi A1 Giuseppe Bruno A1 Paolo Maggi A1 Anna Volpe A1 Paola Vitiello A1 Clara Abeli A1 Stefano Bonora A1 Micol Ferrara A1 Maria Vittoria Cossu A1 Maria Letizia Oreni A1 Elisa Colella A1 Stefano Rusconi PB Taylor & Francis Group YR 2020 K1 hiv-1 K1 darunavir K1 rilpivirine K1 dual therapy K1 immunovirological success K1 safety K1 Infectious and parasitic diseases K1 RC109-216 JF http://dx.doi.org/10.1080/25787489.2020.1734752 LK http://dx.doi.org/https://doi.org/10.1080/25787489.2020.1734752 DO https://doi.org/10.1080/25787489.2020.1734752 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)